Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.15 | 0.001 |
mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.13 | 0.003 |
mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.13 | 0.02 |
mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.089 | 0.05 |
mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.087 | 0.06 |
mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.082 | 0.09 |
mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.071 | 0.1 |
mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.073 | 0.1 |
mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.075 | 0.1 |
mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.055 | 0.2 |